Traditional Chinese medicine compounded oral preparation for treating chronic non-bacterial prostatitis and preparation process therefor

Abstract

The invention belongs to refractory surgical diseases of traditional Chinese medicine and provides a traditional Chinese medicine compounded oral preparation for treating chronic non-bacterial prostatitis and a preparation process therefor. The traditional Chinese medicine compounded oral preparation comprises the following raw materials in parts by weight: 15-50 parts of rhizoma smilacis glabrae,10-30 parts of lonicera japonica, 10-30 parts of rhizoma dioscoreae hypoglaueae, 10-30 parts of herba lysimachiae, 10-30 parts of herba verbenae, 10-30 parts of giant knotweeds, 10-30 parts of cowherb seeds and 5-20 parts of spina gleditsiae. The traditional Chinese medicine compounded oral preparation not only can be used for improving clinical symptoms such as pain discomfort and urination disorder, but also has a remarkable treatment effect in the aspects of improving quality of life and reducing a WBC count in EPS. Discovered through clinical researches, the traditional Chinese medicine compounded oral preparation provided by the invention has a good healing effect on the chronic non-bacterial prostatitis, the effective rate can reach up to 91.4% after 1 month of use, and the recurrence rate is low; and the oral administration is simple, and the traditional Chinese medicine compounded oral preparation is directly taken with warm water, reaches a focus, and is easily taken by a sufferer.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a compound oral preparation of traditional Chinese medicines for treating chronic nonbacterial prostatitis. Background technique [0002] Chronic prostatitis is one of the common diseases in urology and andrology. The incidence rate of chronic prostatitis reported in China is 6.0%-32.9%, and the high incidence stage is men aged 20-50. In recent years, the incidence rate has shown an obvious upward trend. Among them, type III prostatitis accounts for more than 90% of chronic prostatitis. The clinical manifestations of type III prostatitis are mainly two aspects: abnormal urination and local pain and discomfort. Abnormal urination manifests as mild to severe or recurrent urethral burning or pain, urination discomfort, frequent urination, urgency, painful urination, waiting to urinate, incomplete urination, urine dribbling and defecation, "drip white" phenomeno...

AI Technical Summary

Problems solved by technology

External treatment of internal diseases can be administered through the human body surface, pores and meridian points, with direct effect, flexible selection of drugs based on syndrome differentiation, various routes of administration, no liver first-pass effect, and not affected by gastrointestinal degradation. There are many shortcomings The compliance of external treatment is poor, and the doctor's operation is cumbersome

Images